Liposuction in Warsaw Poland
The procedure can "sculpture " your body by removing extra fat from tummy, buttocks, arms, knees, cheeks and neck.. You must remember that liposuction is not an alternative for diet and exercise, it's main target is to help remove extra fat from areas in which fat reduction cannot be done successfully by dieting.
The ideal candidates for the surgery are people with normal weight, elastic skin and areas of "fat pockets" in their body. There are no age limits but older people has less elastic skin and therefore might get results that are worse then the younger patients.
Liposuction can be done by several techniques: solution injection - in which the surgeon injects a special solution to the fat tissue. The solution consists of anesthetics to reduce pain. Adrenalin to reduce bleeding and fluid to help separate the fat from the tissue.
The tumescent technique - much larger amounts of solution is being injected. Surgeons use this method, which allows to inject large amounts of anesthetics, and therefore this kind of procedure can be done with local anesthetics. The operation usually takes longer than the first one (4-5 hours).
The super wet technique in which the amount of solution injected equals the amount of fat tissue removed. This method also takes longer time and has to be done with general anesthetics.
Ultrasound assisted lipoplasty is another technique in which sound waves targeted to fat tissue. The waves break the connection between the fat cells, which are then being removed by suction. This method can be used in areas with connective tissue like the back and male breasts and also in areas that require more precise suction.
After the surgery to avoid swelling the areas of the suction will have elastic bandages. The surgeon may also leave draining tubes to prevent fluid collection. You might also receive antibiotics to prevent an infection.
Every surgery has its complications. In liposuction of 5 liter of fat and more there is a risk of fat or clot emboli to the lungs and even death. Extra fluids might be difficult to remove. The suction tube may cause skin necrosis or alter sensation in the area due to nerve damage. The ultrasound technique regarded as relatively safe produces, but it is a new one therefore the long term damage still unknown. In general, the surgery presents an extra rick for patients with diabetes, lung and heart disease and for those who had similar procedure in the past.
More Warsaw info...
Warsaw Warsaw Commuter Railway
WKD [11] (Polish: Warszawska Kolej Dojazdowa) is separate train service that runs from a distinct platform at Warszawa ?r?dmie?cie to Grodzisk Mazowiecki, a city some 50 km west of Warsaw through Pruszk?w, Milan?wek, and Podkowa Le?na.
-
Warsaw Airport bus services
Bus route ?175? is the service you will probably want to take but watch out as it is notorious for pickpockets.
The cheapest way to get to and from the airport is by bus. Buy a ticket (2.40 z? [5]) before boarding and validate it as you enter the bus. There are three main airport bus routes [6]:
-
LiposuctionLatest Forum Posts...
- Hello! I have friends whose daughters are getting so interested in lipo. Does anyone know if there is any age requirement for lipo? Is it safe for younger people? Thanks!
Plastic Surgery News...
- Starting nicotine replacement therapy (NRT) as a transdermal patch before the target quit date doubles success rates according to a meta-analysis, although only four studies of varied design were eligible for analysis.
The authors of the analysis note that starting NRT before the quit date might improve smoking cessation rates by acclimatising users and separating nicotine intake from smoking. This approach has been most studied using transdermal patches, however trials have varied in size and duration. The aim of this analysis was to determine from the trial data whether a clear benefit had been shown. The authors searched for randomised controlled trials in which the effects of pre-quit treatment were compared directly with treatment starting on the target quit day. Eligible studies recruited smokers who were interested in quitting (rather than reduction), where all participants received NRT from the target quit date, where participants were randomised to receive pre-quit NRT or control (placebo or no NRT), and where cessation was verified 4 to 6 weeks later by biochemical analysis. Primary end-point for the analysis was continuous abstinence for at least 28 days assessed at 6 weeks following quit day, or the nearest reported outcome where this was not available; outcomes at six months were examined as secondary endpoints.
Four trials (n=755) were available and eligible for analysis, all involving nicotine patches: two trials involving nicotine gum were also located, however one was ineligible as a different pre-quit dose was used, and the second had not yet completed. The trials had different designs and durations, and two (n=176) also included treatment with mecamylamine (a nicotinic antagonist). Three studies originated from the same research team.
Analysis found that pre-quit treatment approximately doubled the quit rate at six weeks compared to starting NRT on the quit day (odds ratio 1.91; 95% CI, 1.31 to 2.93). A similar pattern was seen with results at six months (OR 2.17; 95% CI, 1.46 to 3.22). Co-administration of mecamylamine seemed to make no significant difference to the results. There was no evidence that one study was significantly influencing the pooled result - exclusion of each from analysis made little difference to the overall result.
Based on their analysis, the authors conclude that starting NRT patch therapy before the target quit date roughly doubles the chance of success, both in the short-term and up to six months. Although the studies differed widely in their design, the authors consider that the analysis suggests a consistent effect. They note that where the information was collected, there was spontaneous pre-quit reduction in smoking by subjects in the pre-quit group although none were instructed to do this. They discuss possible mechanisms for the effect including pharmacodynamic effects, effects on learned associations involved in smoking, and on extinction of smoking reinforcement.
[Editor's comment: an interesting analysis that appears to have been carefully done, but some cautions remain: the number of participants was relatively small, and it is a slight concern that most of the data came from one research team. This technique would not be covered by current NICE guidance on smoking cessation, and it is uncertain whether it would fit with the current product licences for NRT patches.]
- Eye-Com Corporation, the leader in wearable eye-tracking technology, will be exhibiting its eye-tracking technology at The Game Developers Conference 2008, February 20-22 at Moscone Center in San Francisco, California. Eye-Com has partnered up with NeuroSky, Inc.